Table 2 Distribution of ORCs and obesity stages across tertiles of serum RC concentration
From: Remnant cholesterol in obesity phenotypes: results from NHANES
Character | Tertiles of serum RC concentration | P for trend | ||
|---|---|---|---|---|
Tertile 1 | Tertile 2 | Tertile 3 | ||
Prediabetes, metabolic syndrome, and type 2 diabetes | < 0.001 | |||
Stage 0 | 1(0.05) | 3(0.29) | 0(0.00) | |
Stage 1 | 927(89.55) | 836(80.8) | 675(65.89) | |
Stage 2 | 142(10.4) | 233(18.91) | 390(34.11) | |
Hypertension | < 0.001 | |||
Stage 0 | 846(81.02) | 783(75.77) | 711(67.25) | |
Stage 1 | 44(5.30) | 70(7.07) | 33(2.77) | |
Stage 2 | 180(13.68) | 219(17.16) | 321(29.98) | |
Hypertriglyceridemia/Dyslipidemia | < 0.001 | |||
Stage 0 | 858(81.88) | 723(69.75) | 159(14.36) | |
Stage 1 | 131(12.12) | 184(16.14) | 271(26.15) | |
Stage 2 | 81(6.00) | 165(14.11) | 635(59.49) | |
Non-alcoholic fatty liver disease | < 0.001 | |||
Stage 0 | 753(71.13) | 526(49.1) | 234(20.48) | |
Stage 1 | 304(27.78) | 532(50.18) | 824(78.28) | |
Stage 2 | 13(1.08) | 14(0.73) | 7(1.24) | |
Osteoarthritis | < 0.05 | |||
Stage 0 | 1053(97.92) | 1058(98.11) | 1032(96.42) | |
Stage 1 | 16(2.02) | 12(1.8) | 26(2.94) | |
Stage 2 | 1(0.06) | 2(0.09) | 7(0.64) | |
Stress and urge urinary incontinence | 0.53 | |||
Stage 0 | 840(78.74) | 836(77.12) | 833(77.81) | |
Stage 1 | 216(19.75) | 216(21.35) | 201(19.71) | |
Stage 2 | 14(1.51) | 20(1.53) | 31(2.48) | |
Disability/Immobility | < 0.001 | |||
Stage 0 | 947(88.8) | 908(83.98) | 891(82.32) | |
Stage 1 | 119(10.95) | 148(14.98) | 158(16.38) | |
Stage 2 | 4(0.24) | 16(1.05) | 16(1.31) | |
Psychological disorder/Stigmatization | < 0.001 | |||
Stage 0 | 1013(95.34) | 998(93.43) | 949(89.24) | |
Stage 1 | 49(4.05) | 62(5.89) | 100(9.3) | |
Stage 2 | 8(0.61) | 12(0.68) | 16(1.45) | |
Obesity stages | < 0.001 | |||
Stage 0 | 0(0) | 0(0) | 0(0) | |
Stage 1 | 737(73.45) | 629(62.58) | 339(32.46) | |
Stage 2 | 333(26.55) | 443(37.42) | 726(67.54) | |